Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Key Publications

PubMed: Emma Börgeson

Meenu Rohin Rajan, Matus Sotak, Fredrik Barrenäs, Tong Shen, Kamil Borkowski, Nicholas J Ashton, Christina Biörserud, Tomas L Lindahl, Sofia Ramström, Michael Schöll et al.
Comparative analysis of obesity-related cardiometabolic and renal biomarkers in human plasma and serum.
Scientific reports Oct 28;9(1):15385. (2019) doi: 10.1038/s41598-019-51673-0.

Key original papers

Börgeson E, Wallenius V, Syed GH, Darshi M, Lantero Rodriguez J, Biörserud C, Ragnmark Ek M, Björklund P, Quiding-Järbrink M, Fändriks L, Godson C, Sharma K.
AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin.
Diabetologia. 60(4):729-739 (2017). PMID: 28188334

Börgeson E, Johnsson A, Lee Y.S., Till A, Syed H, Ali-Shah, Guiry P, Dalli D, Colas R, Serhan CN, Godson C, Sharma K.
Lipoxin A4 attenuates obesity-induced adipose inflammation, liver and kidney disease.
Cell Metabolism. 7;22(1):125-37 (2015). PMID:26052006

Börgeson E, McGillicuddy FC, Harford KA, Corrigan N, Higgins DF, Maderna P, Roche HM, Godson C.
Lipoxin A4 attenuates adipose inflammation.
FASEB Journal. 26(10):4287-94 (2012). PMID: 22700871

Börgeson E, Docherty NG, Murphy M, Rodgers K, Ryan A, O'Sullivan TP, Guiry PJ, Goldschmeding R, Higgins DF, Godson C.
Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis.
FASEB Journal. 25(9):2967-79. (2011). PMID: 21628447

Börgeson E, Lönn J, Bergström I, Brodin VP, Ramström S, Nayeri F, Särndahl E, Bengtsson T.
Lipoxin A4 inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression.
Infection and Immunity 79(4):1489-97. (2011). PMID: 21263017

Key review papers

Börgeson E.
The role of lipoxins in cardiometabolic physiology and disease.
Cardiovascular Endocrinology Journal, October 28, doi: 10.1097/XCE.0000000000000068. (2015).

Börgeson E, Sharma K.
Obesity, immunomodulation and chronic kidney disease.
Current Opinion in Pharmacol. 13(4):618-24. (2013). PMID: 23751262

Börgeson E, Godson C.
Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications.
Frontiers in Immunology, 18;3:318. (2012). PMID: 23087692

grafik
Page Manager: Mattias Lindgren|Last update: 12/6/2019
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?